Oric Pharmaceuticals Stock

Oric Pharmaceuticals Dividend 2024

Oric Pharmaceuticals Dividend

0 USD

Oric Pharmaceuticals Dividend yield

Ticker

ORIC

ISIN

US68622P1093

WKN

A2P208

How much dividend does Oric Pharmaceuticals 2024 pay?

According to the latest status from September 2024, Oric Pharmaceuticals paid a total of 0 USD per share in dividends within the last 12 months. With the current Oric Pharmaceuticals price of 10.67 USD, this corresponds to a dividend yield of 0 %. A dividend is paid times per year.

=

Historical Oric Pharmaceuticals Dividends

A dividend is paid times per year. Last year, the payout months were and .

PaydateDividend

Is the Oric Pharmaceuticals Dividend Safe?

Oric Pharmaceuticals has been increasing the dividend for 0 years.

Over the past 6 years, Oric Pharmaceuticals has increased it by an annual 0 %.

Over a five-year period, the distribution increased by 0%.

Analysts expect a Dividend Cut of -100% for the current fiscal year.

Dividend Details

Understanding Oric Pharmaceuticals's Dividend Distributions

Oric Pharmaceuticals’s dividends are a portion of the company’s profits distributed to shareholders. It is a critical indicator of the company’s financial health and attractiveness to investors. Dividends provide investors with a steady income stream, in addition to any profits that may come from selling the stock at a higher price than the purchase price.

Year-to-Year Comparison

Examining Oric Pharmaceuticals's dividend distributions over the years can highlight the company’s profitability and stability. A consistent or increasing dividend payout can indicate a financially healthy company with predictable earnings, while fluctuations or reductions in dividends can suggest underlying financial or operational challenges.

Impact on Investments

Oric Pharmaceuticals's dividend payments are an essential factor for income-focused investors. A robust dividend payout can enhance the stock’s appeal, offering regular income in addition to potential capital gains. It also can indicate the company's confidence in its future earnings, making it a significant consideration in investment decisions.

Interpreting Dividend Fluctuations

Changes in Oric Pharmaceuticals’s dividends can result from shifts in the company’s earnings, financial policies, or reinvestment strategies. An increase in dividends often signals financial stability, while a decrease may indicate a need to conserve cash or reinvest profits to fuel growth, each scenario having different implications for investors.

Oric Pharmaceuticals Aktienanalyse

What does Oric Pharmaceuticals do?

Oric Pharmaceuticals Inc. is a biotechnology company focused on the discovery and development of novel therapeutic approaches for cancer. The company was founded in 2014 by an experienced management team and reputable investors with extensive knowledge in the development and commercialization of cancer drugs. The company is headquartered in Durham, North Carolina, USA. Oric Pharmaceuticals operates a unique business model that focuses on the development of drugs that specifically target cancer cells, thereby increasing therapeutic effectiveness and reducing side effects. The company utilizes a combination of advanced technologies such as genomics, proteomics, and artificial intelligence to develop novel compounds and treatment approaches. The company conducts its research in two business areas: 1) Refinement of the Oric-006 program: The Oric-006 program is a focus of Oric Pharmaceuticals, involving a novel approach to combating cancer. The company has discovered that the protein kinase inhibitor, or Oric-006, is capable of killing tumor cells in patients with advanced tumors. Additionally, the medication is able to slow the spread and inhibit the growth of cancer cells. The company is researching the refinement of Oric-006 and is currently in phase 1b/2 clinical trials. 2) Development of additional compounds: Oric Pharmaceuticals focuses on the development of further therapeutic approaches that can be specifically utilized against specific types of cancer. The company is working on various technologies and platforms to develop new compounds and test their effects against cancer cells. Oric Pharmaceuticals' products have the potential to positively impact the lives of cancer patients and reduce the need for chemotherapy and radiation therapy. The company recognizes the necessity for personalized medicine and utilizes it in the identification of new therapeutic approaches. The company plans to bring its products to market through partnerships and targeted marketing. Oric Pharmaceuticals collaborates closely with experts and leading research institutions for the marketing of their products. Overall, Oric Pharmaceuticals is an innovative company that could play a leading role in the industry due to its focus on personalized cancer medicine and the utilization of cutting-edge technologies. With an experienced management team and reputable investors, the company is positioned for further growth in the future. Oric Pharmaceuticals is one of the most popular companies on Eulerpool.com.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Frequently Asked Questions about Oric Pharmaceuticals stock

How much dividend does Oric Pharmaceuticals pay?

Over the past 12 months, Oric Pharmaceuticals paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Oric Pharmaceuticals is expected to pay a dividend of 0 USD.

What is the dividend yield of Oric Pharmaceuticals?

The current dividend yield of Oric Pharmaceuticals is .

When does Oric Pharmaceuticals pay dividends?

Oric Pharmaceuticals pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Oric Pharmaceuticals?

Oric Pharmaceuticals paid dividends every year for the past 0 years.

What is the dividend of Oric Pharmaceuticals?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Oric Pharmaceuticals located?

Oric Pharmaceuticals is assigned to the 'Health' sector.

Wann musste ich die Aktien von Oric Pharmaceuticals kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Oric Pharmaceuticals from 9/19/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 9/19/2024.

When did Oric Pharmaceuticals pay the last dividend?

The last dividend was paid out on 9/19/2024.

What was the dividend of Oric Pharmaceuticals in the year 2023?

In the year 2023, Oric Pharmaceuticals distributed 0 USD as dividends.

In which currency does Oric Pharmaceuticals pay out the dividend?

The dividends of Oric Pharmaceuticals are distributed in USD.

Andere Kennzahlen von Oric Pharmaceuticals

Our stock analysis for Oric Pharmaceuticals Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Oric Pharmaceuticals Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.